YIBAI PHARMACEUTICAL(SH:600594) Shang Hai Zheng Quan Bao·2026-01-12 18:16Group 1 - The company, Guizhou Yibai Pharmaceutical Co., Ltd., expects a net profit attributable to shareholders to be negative for the fiscal year 2025, indicating an anticipated loss in operating performance [1] - The company will adhere to the relevant regulations of the Shanghai Stock Exchange and expedite its financial accounting process to disclose the 2025 annual performance forecast within the stipulated timeframe [1] - Final financial data will be based on the officially disclosed audited annual report for 2025 [1] Group 2 - The announcement emphasizes the importance of accurate and complete information disclosure, with the board of directors ensuring there are no false records or misleading statements [1] - Designated media for information disclosure include Securities Times, Securities Daily, Shanghai Securities Journal, China Securities Journal, and the Shanghai Stock Exchange website [1]